ARK Invest increased holdings in Meta and Pacific Biosciences, trimming positions in Teradyne, Palantir and others yesterday.

According to disclosures by ARK Invest, Cathie Wood's ARK funds adjusted positions in multiple individual stocks. Purchases: • Meta Platforms (META): ARKK purchased 28,069 shares, accounting for 0.2901% of the fund. ARKW purchased 7,018 shares, accounting for 0.2442%. ARKF purchased 3,023 shares, accounting for 0.2455%. • Pacific Biosciences (PACB): ARKK purchased 266,184 shares, accounting for 0.0089%. ARKG purchased 88,512 shares, accounting for 0.0094%. • ARKG also purchased 99,254 shares of Scribe Therapeutics (SCTX), accounting for 0.0877%. It simultaneously acquired 35,377 shares of Freenome (FRNM), accounting for 0.0229%, and 6,604 shares of Iambic Therapeutics (IAM), accounting for 0.0051%. • ARKW purchased 5,397 shares of Shopify (SHOP), accounting for 0.0482%. Sales: • ARKK sold 57,444 shares of Teradyne (TER), accounting for 0.2836%. • ARKW sold 3